• Citations Per Year
Learn More
Methods An active prospective surveillance for CLABSI at ICU was conducted between January and December 2012. Trained infection control preventionist conducted the surveillance based on the CDC/NHSN (Centers Disease control and Prevention/National Health Care Safety Network) definition of CLABSI and the NHSN methodology for data collection. Rates were(More)
Methods We conducted a prospective surveillance study in eight different ICUs; five adult and three pediatric/neonatal ICUs at King Abdulaziz Medical City, Riyadh, Saudi Arabia, Riyadh, from October 2012 through December 2013. We estimated the consumption of carbapenems as days of use (which was defined as the aggregate sum of days for which any amount of(More)
Results A total of 248 isolates including 9 different pathogens were included.Acinetobacter spp. was highly (70-90%) resistant to all tested antimicrobials including carbapenems (threeand four-class MDR prevalence were 86% and 78%, respectively). Pseudomonas aeruginosa was moderately (20-40%) resistant to all tested antimicrobials including antipseudomonal(More)
Results A total of 457 pathogens were identified during the study; 380 (83.2%) were associated with primary VAP and 77 (16.8%) were associated with recurrent VAP. Of primary VAP pathogens, 159 (41.8%) were associated with early-onset (<5 days) and 221 (58.2%) were associated with late-onset (≥5 days) VAP. The most common pathogens identified were(More)
  • 1